PortfoliosLab logoPortfoliosLab logo
ISIN
US42238H1086
CUSIP
42238H108
IPO Date
Nov 11, 2021

Highlights

Market Cap
$17.24M
Enterprise Value
$15.20M
EPS (TTM)
-$0.56
EBITDA (TTM)
-$20.29M
Year Range
$0.49 - $4.00
Target Price
$5.50
ROA (TTM)
-514.91%
ROE (TTM)
-3,185.98%
Avg. Volume (1M)
1M
Avg. Volume Value (1M)
$598.50K

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Heartbeam, Inc.

Performance

BEAT Performance Chart

Heartbeam, Inc. (BEAT) is down 79.1% since the beginning of the year. At $1 per share, BEAT is trading 87.5% below its 52-week high of $4.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

Heartbeam, Inc. (BEAT) has returned -79.14% so far this year and -50.92% over the past 12 months.


Heartbeam, Inc.

1D
-3.21%
1M
-30.47%
6M
-65.48%
YTD
-79.14%
1Y
-50.92%
3Y*
-45.19%
5Y*
10Y*
ALL TIME*
-39.60%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BEAT Monthly Returns History

Based on dividend-adjusted daily data since Nov 11, 2021, BEAT's average daily return is +0.05%, while the average monthly return is +2.20%. At this rate, an investment would double in approximately 2.7 years.

Historically, 42% of months were positive and 58% were negative. The best month was Dec 2025 with a return of +211.7%, while the worst month was Nov 2025 at -58.4%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.

On a daily basis, BEAT closed higher 42% of trading days. The best single day was Dec 10, 2025 with a return of +92.4%, while the worst single day was Nov 21, 2025 at -53.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-39.58%4.14%-19.21%-29.66%1.97%-14.29%-33.25%-79.14%
20254.35%-15.83%-0.50%-12.94%-2.86%-26.47%-9.60%19.47%22.22%12.12%-58.38%211.69%4.35%
2024-20.43%-22.46%50.34%-7.80%38.31%-7.55%1.56%-9.96%-1.28%4.31%26.45%-24.84%-2.13%
2023-20.70%-10.34%-34.58%-0.44%3.98%2.55%26.14%-31.25%2.87%-42.33%16.94%62.07%-51.84%
2022-29.55%-19.35%5.37%-25.70%5.84%-11.03%9.30%-9.22%204.69%-14.62%28.23%14.29%58.44%
2021-33.89%-13.73%-42.96%

Benchmark Metrics

Heartbeam, Inc. has an annualized alpha of -0.97%, beta of 1.09, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since November 11, 2021.

  • This stock participated in 152.65% of S&P 500 Index downside but only -46.04% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-0.97%
Beta
1.09
0.03
Upside Capture
-46.04%
Downside Capture
152.65%

Return for Risk

Risk / Return Rank

BEAT ranks 30 for risk / return — above 30% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.


BEAT Risk / Return Rank: 3030
Overall Rank
BEAT Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
BEAT Sortino Ratio Rank: 4141
Sortino Ratio Rank
BEAT Omega Ratio Rank: 4141
Omega Ratio Rank
BEAT Calmar Ratio Rank: 1919
Calmar Ratio Rank
BEAT Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for Heartbeam, Inc. (BEAT) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BEATBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.78

Sortino ratioReturn per unit of downside risk

-1.68

Omega ratioGain probability vs. loss probability

1.04

1.25

-0.22

Calmar ratioReturn relative to maximum drawdown

-0.65

2.00

-2.66

Martin ratioReturn relative to average drawdown

-1.03

8.49

-9.52

Dividends

Dividend History


Heartbeam, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Heartbeam, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Heartbeam, Inc. was 91.57%, occurring on Jul 31, 2026. The portfolio has not yet recovered.

The current Heartbeam, Inc. drawdown is 91.57%.


Drawdown

Fall

Recovery

Underwater

Related event

-91.57%Jul 2026
3y 7mo
3y 7moDec 2022 - now
-78.15%Sep 2022
9mo 25d1mo 4d
10mo 29dNov 2021 - Oct 2022
Bear market2022
-50.17%Oct 2022
15d1mo 14d
1mo 29dOct 2022 - Dec 2022
Bear market2022
-5.64%Dec 2022
1d4d
4dDec 2022 - Dec 2022
Bear market2022

Drawdown Indicators


BEATBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-91.57%

-56.78%

-34.79%

Max Drawdown (1Y)

Largest decline over 1 year

-85.45%

-9.10%

-76.35%

Max Drawdown (3Y)

Largest decline over 3 years

-85.45%

-18.90%

-66.55%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-91.57%

-1.58%

-89.99%

Average Drawdown

Average peak-to-trough decline

-63.51%

-10.70%

-52.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.22%

2.14%

+52.08%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Heartbeam, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Heartbeam, Inc. is priced in the market compared to other companies in the undefined industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BEAT in comparison with other companies in the undefined industry. Currently, BEAT has a P/B value of 32.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with BEAT

Add Heartbeam, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with BEAT